1. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R., and Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341, 556–562.
2. Altice, F. L., Mezger, J. A., Hodges, J., Bruce, R. D., Marinovich, A., Walton, M., Springer, S. A., and Friedland, G. H. (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clinical Infectious Diseases, 38, S376–S387.
3. Auerbach, J. D., and Coates, T. J. (2000). HIV prevention research: accomplishments and challenges for the third decade of AIDS. American Journal of Public Health, 90, 29–32.
4. Ball, A. L. (2002). Overview: Policies and interventions to stem HIV-1 epidemics associated with injecting drug use. In G. Stimson, D. C. Des Jarlais, and A. Ball (Eds.), Drug Injecting and HIV Infection: Global Dimensions and Local Responses (pp. 201–232). London: UCL Press.
5. Ball, J. C., Lange, W. R., Myers, C. P., and Friedman, S. R. (1988). Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior, 29, 214–226.